| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 747,730 | 946,504 | 650,171 | 799,496 | | Cost of Revenue | 501,692 | 644,306 | 449,135 | 554,456 | | | Gross Profit | 246,038 | 302,198 | 201,036 | 245,040 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 193,820 | 197,769 | 183,650 | 188,659 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 16,421 | 16,135 | 16,201 | 16,006 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 35,797 | 88,294 | 1,185 | 40,375 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 34,658 | 88,294 | 1,185 | 40,375 | | Interest Expense | (678) | 264 | 414 | 406 | | Income Before Tax | 35,336 | 88,030 | 771 | 39,969 | | Income Tax Expense | 13,357 | 33,266 | 301 | 15,257 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 21,979 | 54,764 | 470 | 24,712 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,979 | 54,764 | 470 | 24,712 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,979 | $54,764 | $470 | $24,712 |
|
1.23% Nasdaq 
Income Statement
